
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)
Jeffrey Guss, Robert Krause, Jordan Sloshower
(2020)
Open Access | Times Cited: 61
Jeffrey Guss, Robert Krause, Jordan Sloshower
(2020)
Open Access | Times Cited: 61
Showing 1-25 of 61 citing articles:
The Therapeutic Potential of Psilocybin
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2948-2948
Open Access | Times Cited: 156
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2948-2948
Open Access | Times Cited: 156
Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model
Bill Brennan, Alexander B. Belser
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 51
Bill Brennan, Alexander B. Belser
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 51
Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms
Patrick D. Skosnik, Jordan Sloshower, Hamideh Safi-Aghdam, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 687-697
Closed Access | Times Cited: 26
Patrick D. Skosnik, Jordan Sloshower, Hamideh Safi-Aghdam, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 687-697
Closed Access | Times Cited: 26
Is Poorly Assisted Psilocybin Treatment an Increasing Risk?
Eduardo Ekman Schenberg, Franklin King, João Eusébio da Fonseca, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 75-76
Closed Access | Times Cited: 13
Eduardo Ekman Schenberg, Franklin King, João Eusébio da Fonseca, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 75-76
Closed Access | Times Cited: 13
What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes
Elias C. Acevedo, Scott Uhler, Kaitlyn P. White, et al.
Journal of Psychoactive Drugs (2024), pp. 1-10
Closed Access | Times Cited: 8
Elias C. Acevedo, Scott Uhler, Kaitlyn P. White, et al.
Journal of Psychoactive Drugs (2024), pp. 1-10
Closed Access | Times Cited: 8
Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey
Brian S. Barnett, Yvan Beaussant, Franklin King, et al.
Journal of Psychoactive Drugs (2021) Vol. 54, Iss. 3, pp. 269-277
Closed Access | Times Cited: 42
Brian S. Barnett, Yvan Beaussant, Franklin King, et al.
Journal of Psychoactive Drugs (2021) Vol. 54, Iss. 3, pp. 269-277
Closed Access | Times Cited: 42
Psilocybin-Assisted Compassion Focused Therapy for Depression
Wendy Pots, Farid Chakhssi
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 23
Wendy Pots, Farid Chakhssi
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 23
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
M. Ishrat Husain, Daniel M. Blumberger, David Castle, et al.
BJPsych Open (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 16
M. Ishrat Husain, Daniel M. Blumberger, David Castle, et al.
BJPsych Open (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 16
Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use
Daniel Perkins, Simon Ruffell, Kimberley Day, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 14
Daniel Perkins, Simon Ruffell, Kimberley Day, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 14
Philosophy and psychedelics: Frameworks for exceptional experience
Tra-ill Dowie, Julien Tempone-Wiltshire
Journal of Psychedelic Studies (2023) Vol. 7, Iss. 2, pp. 143-150
Open Access | Times Cited: 13
Tra-ill Dowie, Julien Tempone-Wiltshire
Journal of Psychedelic Studies (2023) Vol. 7, Iss. 2, pp. 143-150
Open Access | Times Cited: 13
Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics
Oliver Rumle Hovmand, Emil Deleuran Poulsen, Sidse Arnfred
Journal of Psychopharmacology (2023) Vol. 38, Iss. 1, pp. 19-32
Open Access | Times Cited: 12
Oliver Rumle Hovmand, Emil Deleuran Poulsen, Sidse Arnfred
Journal of Psychopharmacology (2023) Vol. 38, Iss. 1, pp. 19-32
Open Access | Times Cited: 12
A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials
Ronit Kishon, Nadav Liam Modlin, Yael M. Cycowicz, et al.
npj Mental Health Research (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 4
Ronit Kishon, Nadav Liam Modlin, Yael M. Cycowicz, et al.
npj Mental Health Research (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 4
A Psilocybin Experience Gone Wrong: The Importance of Psychedelic Assisted Psychotherapy
Fernando Espí Forcén
Journal of Psychoactive Drugs (2025), pp. 1-3
Closed Access
Fernando Espí Forcén
Journal of Psychoactive Drugs (2025), pp. 1-3
Closed Access
The mindful use of psychiatric medication: Report from the Tel Aviv Psychoactive Clinic Project and a proposed model for psychiatric care
Ido Hartogsohn, Yaron Yavelberg, Omry Ben Ezra
Journal of Psychedelic Studies (2025)
Open Access
Ido Hartogsohn, Yaron Yavelberg, Omry Ben Ezra
Journal of Psychedelic Studies (2025)
Open Access
Psilocybin-Assisted Psychotherapy for Methamphetamine Use Disorder: A Pilot Open-Label Safety and Feasibility Study
Elizabeth Knock, Krista J. Siefried, Gillinder Bedi, et al.
(2025)
Closed Access
Elizabeth Knock, Krista J. Siefried, Gillinder Bedi, et al.
(2025)
Closed Access
Further education in psychedelic-assisted therapy – experiences from Switzerland
Helena D. Aicher, Felix Müller, Peter Gasser
BMC Medical Education (2025) Vol. 25, Iss. 1
Open Access
Helena D. Aicher, Felix Müller, Peter Gasser
BMC Medical Education (2025) Vol. 25, Iss. 1
Open Access
Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial
Jacob S. Aday, Jenna McAfee, Deirdre A. Conroy, et al.
Frontiers in Pain Research (2025) Vol. 6
Open Access
Jacob S. Aday, Jenna McAfee, Deirdre A. Conroy, et al.
Frontiers in Pain Research (2025) Vol. 6
Open Access
Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization
Jennifer Jones
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Jennifer Jones
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Metacognitive Feelings of Epistemic Gain are Central to the Understanding of Psychedelic-Induced Mystical-Type Experiences
Federico Seragnoli, Fabienne Picard, Gabriel Thorens, et al.
Cognitive Therapy and Research (2025)
Open Access
Federico Seragnoli, Fabienne Picard, Gabriel Thorens, et al.
Cognitive Therapy and Research (2025)
Open Access
Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement
Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, et al.
BMJ Open (2025) Vol. 15, Iss. 4, pp. e095992-e095992
Open Access
Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, et al.
BMJ Open (2025) Vol. 15, Iss. 4, pp. e095992-e095992
Open Access
Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy
Agnieszka D. Sekula, Luke A. Downey, Prashanth Puspanathan
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 16
Agnieszka D. Sekula, Luke A. Downey, Prashanth Puspanathan
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 16
Neurobiology of the Antidepressant Effects of Serotonergic Psychedelics: A Narrative Review
Noah Chisamore, Erica Kaczmarek, Gia Han Le, et al.
Current Treatment Options in Psychiatry (2024) Vol. 11, Iss. 2, pp. 90-105
Closed Access | Times Cited: 3
Noah Chisamore, Erica Kaczmarek, Gia Han Le, et al.
Current Treatment Options in Psychiatry (2024) Vol. 11, Iss. 2, pp. 90-105
Closed Access | Times Cited: 3
EMBARK Psychedelic Therapy for Depression
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2
The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences
Tomas Frymann, Sophie Whitney, David B. Yaden, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 12
Tomas Frymann, Sophie Whitney, David B. Yaden, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 12
Psychedelika in der Psychiatrie – Entwicklungen und die Stellung in Deutschland
Uwe Herwig, Lea J. Mertens, Sergio Pérez Rosal, et al.
Fortschritte der Neurologie · Psychiatrie (2023) Vol. 91, Iss. 07/08, pp. 311-318
Closed Access | Times Cited: 5
Uwe Herwig, Lea J. Mertens, Sergio Pérez Rosal, et al.
Fortschritte der Neurologie · Psychiatrie (2023) Vol. 91, Iss. 07/08, pp. 311-318
Closed Access | Times Cited: 5